Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide Taken as 5 Days Per Week
Clinical trial NCT06773754 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06773754
- Sponsor
- National Taiwan University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2023-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.